Nuvalent (NUVL) Current Assets (2020 - 2026)
Nuvalent (NUVL) reported Current Assets of $1.3 billion for Q1 2026, up 20.37% on a YoY basis from $1.1 billion in Q1 2025, and down 6.07% quarter-over-quarter from $1.4 billion in Q4 2025.
Nuvalent (NUVL) Current Assets (2020 - 2026) Analysis & Trends
Nuvalent has reported Current Assets for 7 years, with the latest figure at $1.3 billion in Q1 2026.
- For the quarter ending Q1 2026, Current Assets rose 20.37% year-over-year to $1.3 billion; the trailing twelve-month figure through Mar 2026 stood at $1.3 billion (up 20.37% YoY), and the FY2025 full-year result was $1.4 billion, up 22.96% from the prior year.
- Current Assets for Q1 2026 stood at $1.3 billion, down from $1.4 billion in the prior quarter.
- The five-year high for Current Assets was $1.4 billion in Q4 2025, with the low at $245.2 million in Q3 2022.
- Historically, Current Assets has averaged $749.3 million across 5 years, with a median of $699.5 million in 2024.
- Annual changes were most pronounced in 2022 — Current Assets fell 19.63% — and 2024, when it surged 181.03%.
- Nuvalent's Current Assets stood at $478.0 million in 2022, then jumped by 51.99% to $726.5 million in 2023, then jumped by 55.88% to $1.1 billion in 2024, then increased by 22.96% to $1.4 billion in 2025, then declined by 6.07% to $1.3 billion in 2026.
- The last three Current Assets figures came in at $1.3 billion (Q1 2026), $1.4 billion (Q4 2025), and $956.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 37.31 Mn |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | 521.86 Mn |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 10.37 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 1.25 Bn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 3.59 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 7.63 Mn |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 11.73 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 600.85 Mn |
| 10 | Nuvalent | 9.70 Bn | 9.70 Bn | - | 1.31 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.31 Bn |
| Dec 31, 2025 | 1.39 Bn |
| Sep 30, 2025 | 956.95 Mn |
| Jun 30, 2025 | 1.02 Bn |
| Mar 31, 2025 | 1.09 Bn |
| Dec 31, 2024 | 1.13 Bn |
| Sep 30, 2024 | 1.18 Bn |
| Jun 30, 2024 | 666.26 Mn |
| Mar 31, 2024 | 699.49 Mn |
| Dec 31, 2023 | 726.49 Mn |
| Sep 30, 2023 | 419.77 Mn |
| Jun 30, 2023 | 436.99 Mn |
| Mar 31, 2023 | 456.29 Mn |
| Dec 31, 2022 | 477.99 Mn |
| Sep 30, 2022 | 245.25 Mn |
| Jun 30, 2022 | 258.82 Mn |
| Mar 31, 2022 | 274.47 Mn |
| Dec 31, 2021 | 290.63 Mn |
| Sep 30, 2021 | 305.14 Mn |
| Jun 30, 2021 | 139.28 Mn |